Alterity Therapeutics Limited | PRAN - Ebit


Alterity Therapeutics Limited reported AUD-7.77M in EBIT for its fiscal semester ending in June of 2023.





Ebit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Arca Biopharma USD -25.09M 5.23M Mar/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
CSL USD 2.75B 1.35B Dec/2024
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
Immunic USD -22.81M 756K Jun/2024
Insmed USD -261.35M 7.48M Sep/2025
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
TherapeuticsMD USD -1.77M 699K Sep/2023